10/25/2010 9:32:06 AM
BRIDGEWATER, N.J., Oct. 22, 2010 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), announced today the pricing of its initial public offering of 5,000,000 shares of its common stock at $9.50 per share, before underwriting discounts and commissions. All shares are being sold by the company. Aegerion has granted the underwriters an option for 30 days to purchase up to an additional 750,000 shares at the initial public offering price, less underwriting discounts and commissions, to cover over-allotments, if any. The common stock will trade on the NASDAQ under the symbol "AEGR."
comments powered by